HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of immunoglobulin λ light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndrome.

Abstract
The M protein of POEMS syndrome is essentially λ light chain restricted. Several studies have demonstrated the restrict usage of immunoglobulin λ light chain variable region (IGLV) genes in patients with POEMS syndrome. However, these studies only included a limited number of cases, and it is not clear whether the clinical features are influenced by the IGLV gene in POEMS syndrome. Here we demonstrated that the clonal IGLV genes were strictly derived from IGLV 1-40 (11 patients, 36.7 %) and IGLV 1-44 (19, 63.3 %) gene in 30 patients with POEMS syndrome. We further evaluated the relationship between clinical features and IGLV genes. Our study showed that patients with IGLV 1-44 were older than those with IGLV 1-40, and patients with IGLV 1-40 had more severe neuropathy, hypertrichosis, and papilledema. It was suggested that the IGLV gene influenced clinical characteristics in POEMS syndrome.
AuthorsJian Li, Zhen Huang, Ming-hui Duan, Wei Zhang, Miao Chen, Xin-xin Cao, Hong-zhi Guan, Zhuang Tian, Dao-bin Zhou
JournalAnnals of hematology (Ann Hematol) Vol. 91 Issue 8 Pg. 1251-5 (Aug 2012) ISSN: 1432-0584 [Electronic] Germany
PMID22453306 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunoglobulin Light Chains
  • Immunoglobulin Variable Region
  • Immunoglobulin lambda-Chains
Topics
  • Adult
  • Aged
  • Cohort Studies
  • DNA Mutational Analysis (methods)
  • Diagnosis, Differential
  • Female
  • Gene Rearrangement (genetics, immunology)
  • Humans
  • Immunoglobulin Light Chains (analysis, genetics)
  • Immunoglobulin Variable Region (analysis, genetics)
  • Immunoglobulin lambda-Chains (analysis, genetics)
  • Male
  • Middle Aged
  • POEMS Syndrome (diagnosis, genetics, immunology)
  • Prognosis
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: